871 Combining KRASG12C(ON) inhibitor with SHP2 and/or immune checkpoint blockade to overcome adaptive resistance and enhance anti-tumour immunity in lung cancer

• Julian Downward,
• Christopher Moore,
• Panayiotis Anastasiou,
• Sareena Rana,
• Jesse Boumelha,
• Mona Tomaschko,
• Miriam Molina-Arcas

Affiliations

Julian Downward

principal scientist

Christopher Moore

6Welsh Ambulance Services NHS Trust, St Asaph, UK

Panayiotis Anastasiou

The Francis Crick Institute, London, UK

Sareena Rana

The Francis Crick Institute, London, UK

Jesse Boumelha

The Francis Crick Institute, London, UK

Mona Tomaschko

The Francis Crick Institute, London, UK

Miriam Molina-Arcas

The Francis Crick Institute, London, UK